165 related articles for article (PubMed ID: 21751053)
1. Income-related inequity in initiation of evidence-based therapies among patients with acute myocardial infarction.
Hanley GE; Morgan S; Reid RJ
J Gen Intern Med; 2011 Nov; 26(11):1329-35. PubMed ID: 21751053
[TBL] [Abstract][Full Text] [Related]
2. Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.
Korhonen MJ; Robinson JG; Annis IE; Hickson RP; Bell JS; Hartikainen J; Fang G
J Am Coll Cardiol; 2017 Sep; 70(13):1543-1554. PubMed ID: 28935030
[TBL] [Abstract][Full Text] [Related]
3. Use of statins and beta-blockers after acute myocardial infarction according to income and education.
Rasmussen JN; Gislason GH; Rasmussen S; Abildstrom SZ; Schramm TK; Køber L; Diderichsen F; Osler M; Torp-Pedersen C; Madsen M
J Epidemiol Community Health; 2007 Dec; 61(12):1091-7. PubMed ID: 18000133
[TBL] [Abstract][Full Text] [Related]
4. Determinants of Insufficient Optimal Medical Therapy after Acute Myocardial Infarction.
Haraguchi Y; Sakakura K; Yamamoto K; Taniguchi Y; Tsukui T; Seguchi M; Wada H; Momomura SI; Fujita H
Intern Med; 2020 Jun; 59(12):1489-1495. PubMed ID: 32188806
[TBL] [Abstract][Full Text] [Related]
5. Use of evidence-based pharmacotherapy after myocardial infarction in Estonia.
Marandi T; Baburin A; Ainla T
BMC Public Health; 2010 Jun; 10():358. PubMed ID: 20569449
[TBL] [Abstract][Full Text] [Related]
6. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
[TBL] [Abstract][Full Text] [Related]
7. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
[TBL] [Abstract][Full Text] [Related]
8. Racial/Ethnic and gender gaps in the use of and adherence to evidence-based preventive therapies among elderly Medicare Part D beneficiaries after acute myocardial infarction.
Lauffenburger JC; Robinson JG; Oramasionwu C; Fang G
Circulation; 2014 Feb; 129(7):754-63. PubMed ID: 24326988
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
Austin PC; Tu JV; Ko DT; Alter DA
CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
[TBL] [Abstract][Full Text] [Related]
10. Do immigrants from Turkey, Pakistan and Yugoslavia receive adequate medical treatment with beta-blockers and statins after acute myocardial infarction compared with Danish-born residents? A register-based follow-up study.
Hempler NF; Diderichsen F; Larsen FB; Ladelund S; Jørgensen T
Eur J Clin Pharmacol; 2010 Jul; 66(7):735-42. PubMed ID: 20393695
[TBL] [Abstract][Full Text] [Related]
11. Survival prospects after acute myocardial infarction in the UK: a matched cohort study 1987-2011.
Gitsels LA; Kulinskaya E; Steel N
BMJ Open; 2017 Jan; 7(1):e013570. PubMed ID: 28119386
[TBL] [Abstract][Full Text] [Related]
12. Cardiac medication prescribing and adherence after acute myocardial infarction in Chinese and South Asian Canadian patients.
Lai EJ; Grubisic M; Palepu A; Quan H; King KM; Khan NA
BMC Cardiovasc Disord; 2011 Sep; 11():56. PubMed ID: 21923931
[TBL] [Abstract][Full Text] [Related]
13. Variation in initiating secondary prevention after myocardial infarction by hospitals and physicians, 1997 through 2004.
Margulis AV; Choudhry NK; Dormuth CR; Schneeweiss S
Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1088-97. PubMed ID: 21538672
[TBL] [Abstract][Full Text] [Related]
14. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction.
Gislason GH; Rasmussen JN; Abildstrøm SZ; Gadsbøll N; Buch P; Friberg J; Rasmussen S; Køber L; Stender S; Madsen M; Torp-Pedersen C
Eur Heart J; 2006 May; 27(10):1153-8. PubMed ID: 16399775
[TBL] [Abstract][Full Text] [Related]
15. Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000.
Pilote L; Beck CA; Karp I; Alter D; Austin P; Cox J; Humphries K; Jackevicius C; Richard H; Tu JV;
Can J Cardiol; 2004 Jan; 20(1):61-7. PubMed ID: 14968144
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
[TBL] [Abstract][Full Text] [Related]
18. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
Hudson M; Richard H; Pilote L
Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):773-85. PubMed ID: 17486661
[TBL] [Abstract][Full Text] [Related]
19. Use of cardiovascular drugs after acute myocardial infarction: a marked shift towards evidence-based drug therapy.
Reikvam A; Kvan E; Aursnes I
Cardiovasc Drugs Ther; 2002 Sep; 16(5):451-6. PubMed ID: 12652115
[TBL] [Abstract][Full Text] [Related]
20. Sex Disparities in Post-Acute Myocardial Infarction Pharmacologic Treatment Initiation and Adherence: Problem for Young Women.
Smolina K; Ball L; Humphries KH; Khan N; Morgan SG
Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):586-92. PubMed ID: 26462876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
